Ascent Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.18M | Sell |
7,844
-1,007
| -11% | -$408K | 0.12% | 162 |
|
2025
Q1 | $4.4M | Buy |
8,851
+1,454
| +20% | +$724K | 0.19% | 117 |
|
2024
Q4 | $3.85M | Sell |
7,397
-699
| -9% | -$364K | 0.29% | 88 |
|
2024
Q3 | $5.01M | Sell |
8,096
-2,933
| -27% | -$1.81M | 0.38% | 57 |
|
2024
Q2 | $6.1M | Buy |
11,029
+561
| +5% | +$310K | 0.5% | 41 |
|
2024
Q1 | $6.08M | Buy |
10,468
+3,484
| +50% | +$2.02M | 0.54% | 33 |
|
2023
Q4 | $3.82M | Buy |
6,984
+24
| +0.3% | +$13.1K | 0.36% | 61 |
|
2023
Q3 | $3.09M | Sell |
6,960
-111
| -2% | -$49.3K | 0.34% | 69 |
|
2023
Q2 | $3.93M | Sell |
7,071
-779
| -10% | -$433K | 0.43% | 53 |
|
2023
Q1 | $4.52M | Sell |
7,850
-876
| -10% | -$505K | 0.48% | 41 |
|
2022
Q4 | $4.81M | Buy |
8,726
+530
| +6% | +$292K | 0.57% | 33 |
|
2022
Q3 | $4.21M | Buy |
8,196
+115
| +1% | +$59.1K | 0.51% | 43 |
|
2022
Q2 | $4.84M | Buy |
8,081
+431
| +6% | +$258K | 0.58% | 32 |
|
2022
Q1 | $4.52M | Sell |
7,650
-23
| -0.3% | -$13.6K | 0.53% | 42 |
|
2021
Q4 | $4.45M | Buy |
+7,673
| New | +$4.45M | 0.57% | 36 |
|